MRNA wins FDA approval for mNexspike, a fridge-stable COVID shot, but with a narrower use label than it sought.

Moderna has announced FDA approval for its new COVID-19 vaccine, mNexspike (mRNA-1283). This next-generation shot targets a ...

The new vaccine, mNexspike (mRNA-1283), is a step toward next-generation coronavirus vaccines. It’s made in a way that allows ...

Despite Health Secretary Robert F Kennedy Jr’s announcement ending covid-19 vaccine recommendations for healthy children and pregnant women, the Centers for Disease Control and Prevention (CDC) has ...

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...

Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...

Exercise may help prevent colon cancer from returning, according to results from a late-phase trial published Sunday, June 1 ...

AI Innovation, Entrepreneurial Culture, M&A Growth, and Operational Excellence Fuel 2025 Recognition PLANO, TEXAS / ACCESS ...

Welcome to the Fox News Politics newsletter, with the latest updates on the Trump administration, Capitol Hill and more Fox ...

Accepting New Patients Dr. Ammar Nassri Dr. Ammar Nassri Rockwall, TX, June 03, 2025 (GLOBE NEWSWIRE) -- Digestive Health ...

Kettering Health, a network with dozens of medical and emergency centers in Ohio, is still working to recover and return to ...

In addition to Barclays, Moderna also received a Hold from Morgan Stanley’s Terence Flynn in a report issued yesterday. However, on May 21, Brookline Capital Markets reiterated a Buy rating on Moderna ...